Head of Global Rare Diseases
Chiesi Global Rare Diseases
Co-Founder and President
Longhorn Vaccines & Diagnostics
Mary-Anne Etiebet, MD
Associate VP of Health Equity
Merck & Co., Inc.
Simba Gill, PhD
Global President of Inflammation & Immunology, Pfizer Inflammation & Immunology
Mark Goldberg, MD
Chairman and CEO
Head of Research & Development
Chief Operating Officer
Athira Pharma, Inc.
Jeremy Levin, D.Phil,MB BChir
President & CEO
Cristian Massacesi, MD
Chief Medical Officer and Oncology Chief Development Officer
G3 Life Sciences
Armon Sharei, PhD
Co-Founder and CEO
Helen Thackery, MD
Chief Research and Development Officer
BioCryst Pharmaceuticals, Inc.
The pandemic changed everything — requiring our PharmaVoice 100 honorees to pivot, be agile, develop new skills, and think about health equity and diversity in a different way. As the industry moves into a post-pandemic phase, there is no going back. The next era of leadership — from molecule to market — will be more focused on patients than ever before and ripe with opportunities for emerging science and talent.
Join PharmaVoice Editor in Chief Emeritus Taren Grom and industry leaders for a full-day event featuring engaging and interactive discussions with your peers and PharmaVoice 100 honorees, followed by a PharmaVoice 100 Celebration ceremony and more networking opportunities.
See below for more information on the sessions.
Session Information (all times listed in EST)
10:00am-11:00am: Welcome and CEO Roundtable: Navigating Uncharted Waters
Your seat has been reserved for the 2022 PharmaVoice 100 Celebration: The Next Era of Leadership. Please check your email for a registration confirmation and further information on accessing the event.
We look forward to seeing you live on September 15th!